コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 is necessary for development of HCV-related lymphoproliferation.
2 t also causes massive double-negative T-cell lymphoproliferation.
3 m autoimmune diabetes without causing T-cell lymphoproliferation.
4 orm infection on host cytokine responses and lymphoproliferation.
5 negatively associated with rubella-specific lymphoproliferation.
6 who developed an Epstein-Barr virus-related lymphoproliferation.
7 itive patients who exhibit envelope-specific lymphoproliferation.
8 on in vitro does not preclude HIV-1-specific lymphoproliferation.
9 ormed to determine the cell type involved in lymphoproliferation.
10 cells are mainly responsible for preventing lymphoproliferation.
11 er monocytes to downregulate mitogen-induced lymphoproliferation.
12 bute to the costimulation of virally induced lymphoproliferation.
13 entify high-risk patients and diagnose early lymphoproliferation.
14 ion of PCD and in the inhibition of in vitro lymphoproliferation.
15 ciency strongly correlated with intensity of lymphoproliferation.
16 a long-term risk of AA amyloidosis and overt lymphoproliferation.
17 markers and were unable to induce allogeneic lymphoproliferation.
18 l dysfunction, perhaps related to EBV-driven lymphoproliferation.
19 isms, impaired production of antibodies, and lymphoproliferation.
20 st patients died of infection or progressive lymphoproliferation.
21 ify high-risk patients and to diagnose early lymphoproliferation.
22 ty, autoantibody production, and substantial lymphoproliferation.
23 confirmed the clonal B-cell nature of these lymphoproliferations.
24 tic target for treatment of some EBV-induced lymphoproliferations.
25 munodeficiency, we studied 39 EBV-associated lymphoproliferations (10 benign, 29 malignant) from four
26 ocyte responses at diagnosis, as measured by lymphoproliferation (7/7) or cytokine flow cytometry (3/
27 inhibition led to a reduction in spontaneous lymphoproliferation, a key ex vivo correlate of the immu
29 ity locus Nba2 causes dramatic B cell and PC lymphoproliferation, accelerated autoantibody production
30 PS) is characterized by chronic nonmalignant lymphoproliferation, accumulation of double-negative T c
31 ng (a) H-TdR incorporation for inhibition of lymphoproliferation and (b) flow cytometry to analyze fo
32 ify the mTOR pathway as a major regulator of lymphoproliferation and aberrant differentiation in ALPS
33 At 4 mo of age, both groups showed extensive lymphoproliferation and aberrant T cell formation, altho
34 e Fas signaling, resulting in chronic benign lymphoproliferation and accumulation of TCRalphabeta(+)
36 had an impaired ability to induce allogeneic lymphoproliferation and activated autologous memory CD4+
40 vo depletion of normal Thy-1+ cells restores lymphoproliferation and autoantibody production in such
44 We found that expression of MC159 led to lymphoproliferation and autoimmunity as exemplified by T
49 le for infectious agents in the induction of lymphoproliferation and B cell autoimmunity in MRL-lpr m
50 pport an etiological role for HCV in causing lymphoproliferation and causing non-Hodgkin lymphoma.
53 monstrated suppression of adenovirus-induced lymphoproliferation and cytokine responses (interleukin-
56 y role for dietary exposure in the extent of lymphoproliferation and development of nephritis in this
57 port on 13 individuals from 10 families with lymphoproliferation and early-onset solid-organ autoimmu
60 pr.H-2(d) mice, both types of mice developed lymphoproliferation and exhibited elevated levels of IgG
62 TLA4Ig treatment of CTLA-4 -/- mice prevents lymphoproliferation and fatal multiorgan tissue damage i
64 ymph nodes (MLN), and spleen were assayed by lymphoproliferation and flow cytometry for the expressio
65 ogical activity of each subset, expressed as lymphoproliferation and gamma interferon (IFN-gamma) pro
66 atients without clinically detectable B-cell lymphoproliferation and generates many large B-cell clon
68 ovide insight into mechanisms of EBV-induced lymphoproliferation and identify potential therapeutic i
70 with this haplotype demonstrated higher mean lymphoproliferation and IFN-gamma secretion than did cel
73 eviously shown to be important in preventing lymphoproliferation and immunodeficiency following infec
74 eficiency syndrome (MAIDS), characterized by lymphoproliferation and immunodeficiency in susceptible
76 of virus-specific T cells and occurrence of lymphoproliferation and inflammatory autoimmune disease
78 tvaccination H3(Beijing/32) HA (H3)-specific lymphoproliferation and interleukin (IL)-2, IL-10, and i
79 on of autoreactive T and B cells, leading to lymphoproliferation and lupus-like autoantibody producti
80 infection of BALB beta2m-/- mice results in lymphoproliferation and lymphoma, providing a valuable t
82 exogenous sphingolipids cause inhibition of lymphoproliferation and PCD by two separate and distinct
84 Mice homozygous for the lpr gene develop lymphoproliferation and produce autoantibodies closely r
85 polyclonal lymphocyte activation leading to lymphoproliferation and severe autoimmune nephritis with
86 )CD25(+) regulatory T cells, exhibit massive lymphoproliferation and severe inflammatory infiltration
87 ty similar to that shown in vitro, including lymphoproliferation and stimulation of interleukin-6 sec
89 ses induced by NP DNA, which included robust lymphoproliferation and Th1-type cytokine secretion (hig
90 significantly down-regulated antigen-induced lymphoproliferation and the expression of interleukin-12
91 ontrols, BEL dose-dependently inhibited both lymphoproliferation and Treg generation in human leukocy
92 activation of T cells (LAT) show progressive lymphoproliferation and ultimately die at 4-6 mo age.
95 s influences the phenotype of the developing lymphoproliferations and potentially the severity of dis
97 logical changes in lymphoid organs, abnormal lymphoproliferation, and a greatly increased incidence o
98 on that leads to abnormalities of apoptosis, lymphoproliferation, and a lupus-like autoimmune disease
100 s, antibody-dependent cellular cytotoxicity, lymphoproliferation, and cytotoxic CD8+ T cell activity
101 patients displayed multiorgan autoimmunity, lymphoproliferation, and delayed-onset mycobacterial dis
104 r protein) cause a syndrome of autoimmunity, lymphoproliferation, and humoral immune deficiency.
107 fects of immunosuppression on EBV-associated lymphoproliferation, and may be an essential technique f
108 e dysregulation manifesting as autoimmunity, lymphoproliferation, and organ inflammation and thereby
109 Knocking out CTLA4 in mice causes lethal lymphoproliferation, and polymorphisms in human CTLA4 ar
110 ns of SNPs with measles-specific antibodies, lymphoproliferation, and secreted cytokines were determi
111 mmatory arthropathy, intermittent polyclonal lymphoproliferation, and significant chronic kidney dise
113 in delayed-type hypersensitivity responses, lymphoproliferation, and spontaneous apoptosis and with
114 tissue, in Epstein-Barr virus (EBV)-induced lymphoproliferations, and in malignant lymphomas with sp
116 ar lymphocytic leukemias (T-LGLs) are clonal lymphoproliferations arising from either natural killer
118 d the activation of autoreactive T cells and lymphoproliferation as well as production of autoantibod
119 repeat RT-PCR, nested DNA PCR, western blot, lymphoproliferation assay, cytotoxic T-cell lysis, CD8-d
123 chronic stimulation of the immune system and lymphoproliferation associated with storage of glucocere
125 s for one such subject revealed Env-specific lymphoproliferation at 11 DPI but no detectable Env-spec
126 family presenting with EBV-associated B-cell lymphoproliferation at an early age (12, 7(1/2), and 14
128 iciency for the IFN-RI surprisingly worsened lymphoproliferation, autoantibody production, and end or
129 apoptosis of lymphocytes is characterized by lymphoproliferation, autoimmunity, but also an increased
130 nt recipients are at high risk of EBV-driven lymphoproliferation because they lack EBV-specific memor
131 s to be required for uncontrolled aggressive lymphoproliferation, because none of the IL-15Ralpha(-/-
133 which was initially attributed to excessive lymphoproliferation but is now ascribed to the absence o
135 e that overexpression of this locus leads to lymphoproliferation, but no experimental proof that dysr
136 e sensitivity of peripheral monitoring for B lymphoproliferation, but the dramatic reduction in PTLD
137 volved in the pathogenesis of several B cell lymphoproliferations, but the precise contribution it ma
138 induced tolerance and double-negative T-cell lymphoproliferation can be uncoupled from each other.
139 tic cows, demonstrating that the spontaneous lymphoproliferation characteristic of BLV-induced persis
140 gnificantly exacerbated the skin disease and lymphoproliferation characteristic of MRL/lpr mice.
141 factor pathway by EBV may contribute to the lymphoproliferation characteristic of type III latency.
143 biopsy revealed an Epstein-Barr virus-driven lymphoproliferation consistent with a polymorphic posttr
145 ayed type hypersensitivity (DTH) and in vivo lymphoproliferation correlated with MMc levels, suggesti
146 E7 and/or L1-specific WIL, as determined by lymphoproliferation, could be isolated from more than 75
149 deleted region (CDR) changed the spectrum of lymphoproliferations developing in CDR- versus MDR-delet
150 e resulting FADD mutant mice did not develop lymphoproliferation diseases, unlike Fas-deficient mice.
151 munodeficiency associated with erythroderma, lymphoproliferation, elevated IgE, and hyperactive oligo
152 the Notch1 intracellular domain resulted in lymphoproliferation, exacerbated T(H)1 responses and aut
154 man immunodeficiency virus-negative atypical lymphoproliferations expressing large amounts of the lat
155 and conventional MRL-lpr mice were noted in lymphoproliferation, flow cytometric analysis of lymph n
157 noculated intradermally into wild type (wt), lymphoproliferation gene (lpr) (Fas deficient), or gener
160 dies, 77% of patients with envelope-specific lymphoproliferation have undetectable anti-CD4bd antibod
162 mber of immunopathologic sequelae, including lymphoproliferation, hypergammaglobulinemia, and overt s
164 o 8 weeks after infection by the criteria of lymphoproliferation, impaired proliferative responses to
165 motes rather than inhibits Bcr-Abl-induced B lymphoproliferation in a murine model where BM cells fro
170 IgM(+) memory B cells as a general target of lymphoproliferation in HCV(+) patients, affecting appare
171 , our findings suggest that autoimmunity and lymphoproliferation in IL-2Ralpha-/- mice can result fro
174 with increased susceptibility to EBV-induced lymphoproliferation in patients associated with hypomorp
175 sensitivity responses and decreased in vitro lymphoproliferation in response to specific antigens hav
176 This approach accomplishes the control of lymphoproliferation in severe forms as well as the minim
178 the marked decrease seen in mitogen-induced lymphoproliferation in the presence of infected monocyte
180 skin test to tuberculin, and antigen-induced lymphoproliferation in vitro were markedly suppressed in
182 recapitulates the spectrum of CLL-associated lymphoproliferations in humans, including CLL, CD5(+) mo
187 differential diagnosis of extranodal T-cell lymphoproliferations, including those in immunosuppresse
188 by the production of anti-nucleolar IgG Abs, lymphoproliferation, increased serum levels of IgG1 and
189 by the production of antinucleolar IgG Abs, lymphoproliferation, increased serum levels of IgG1/IgE
190 constitutively active Raf transgene enhanced lymphoproliferation, indicating a role for the Ras-MAPK
191 ignificantly increased Ag85b-specific T cell lymphoproliferation, interferon (IFN)-gamma secretion, I
193 T3 mutations may distinguish truly malignant lymphoproliferations involving T and NK cells from react
194 Epstein-Barr virus (EBV)-associated B-cell lymphoproliferation is a life-threatening complication a
198 ninfected, nonpregnant mice, suggesting that lymphoproliferation is not a good indicator of the antim
201 was sufficient to trigger aggressive B-cell lymphoproliferation, leading to early postnatal lethalit
202 TLA-4 die at an age of 2-3 wk due to massive lymphoproliferation, leading to lymphocytic infiltration
203 homozygous gld mutations cause age-dependent lymphoproliferation, limiting the gld mutation to one al
207 ween this syndrome and that in mice with the lymphoproliferation (lpr) phenotype or the generalized-l
208 -nonbinding CTLA-4 mutant delayed the lethal lymphoproliferation observed in CTLA-4-deficient mice.
209 prevents all features characteristic of the lymphoproliferation observed in CTLA-4-deficient mice.
210 rlier occurrence of autoantibodies; a higher lymphoproliferation of B and T cells; and an earlier ons
211 ular lymphocyte (T-LGL) leukemia is a clonal lymphoproliferation of cytotoxic T cells (CTLs) associat
212 phocyte (T-LGL) leukemia is a chronic clonal lymphoproliferation of cytotoxic T cells often associate
213 ular lymphocyte leukemia is a chronic clonal lymphoproliferation of cytotoxic T cells often associate
214 eukemia (T-LGLL) is characterized by chronic lymphoproliferation of cytotoxic T lymphocytes (CTLs) an
215 a (T-LGL) is characterized by chronic clonal lymphoproliferation of cytotoxic T lymphocytes (CTLs).
218 on 2 patients demonstrated that spontaneous lymphoproliferation of PBLs was present but decreased re
220 erum antibodies to Chlamydia and significant lymphoproliferation of T-cells following stimulation wit
221 ion at 11 DPI but no detectable Env-specific lymphoproliferation or ex vivo gamma interferon (IFN-gam
223 ey did not develop spontaneous autoimmunity, lymphoproliferation, or germinal center expansion althou
224 ss-switched memory B cells and propensity to lymphoproliferation (P = .002) in patients with CVID.
225 esponses that trended higher than Dryvax for lymphoproliferation (P = .06), but lower for IFN-gamma E
228 that, at least in NZB, the autoimmunity and lymphoproliferation phenotypes are not linked geneticall
229 ts also emphasize the importance of IL-6 for lymphoproliferation, possibly through induction of IL-2R
232 essing gp160/LAMP had greater gp160-specific lymphoproliferation responses and higher titers of anti-
234 entity in which a bone marrow clonal B-cell lymphoproliferation results in autoimmune hemolytic anem
236 L13, SPP1), activated B-cell subtype (MUM1), lymphoproliferation (SPP1, TCL1A, CHI3L1), aggressive cl
240 Unexpectedly, there was no progression of lymphoproliferation through 24 weeks, even though immune
244 autoimmune disease manifestations, including lymphoproliferation, vasculitis, glomerulonephritis, and
245 velop an autoimmune disease characterized by lymphoproliferation, vasculitis, glomerulonephritis, aut
248 d monitoring strategy detecting peripheral B lymphoproliferation was effective in the early diagnosis
252 (purified protein derivative [PPD])-induced lymphoproliferation was markedly impaired in vaccinated
255 mice in that the number of CLL among B-cell lymphoproliferations was significantly elevated in the f
256 nd NF-kappaB activation, IL-2 secretion, and lymphoproliferation were inhibited by fish oil feeding.
257 ells and peripheral tissues played a role in lymphoproliferation, whereas the skin disease phenotype
258 early onset and aggressive polyclonal T cell lymphoproliferation with concomitant B cell expansion an
259 eatment, all patients showed amelioration of lymphoproliferation with lymph node sizes and spleen vol
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。